Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anthony Dayan

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Toxicologic Pathology|April 13, 2002
New tools in therapeutic research--prostatic cancer and modelsAbraham Nyska, Anthony Dayan, Robert R Maronpot
The Journal of Gene Medicine|April 16, 2009
A preclinical assessment of the safety and biodistribution of an adenoviral vector containing the herpes simplex virus thymidine kinase gene (Cerepro) after intracerebral administrationGillian Langford, Anthony Dayan, Seppo Yla-Herttuala, et al.
International Journal of Toxicology|April 9, 2025
A Commentary: Looking Back and Looking SidewaysAnthony Dayan, Peter Pressman, Thomas Blackburn, et al.
Archives of Toxicology|June 20, 2021
Categorizing the characteristics of human carcinogens: a need for specificityCarr J Smith, Thomas A Perfetti, A Wallace Hayes, et al.
Science Translational Medicine|July 17, 2015
A long-duration dihydroorotate dehydrogenase inhibitor (DSM265) for prevention and treatment of malariaMargaret A Phillips, Julie Lotharius, Kennan Marsh, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Toxicologic Pathology|April 13, 2002
New tools in therapeutic research--prostatic cancer and modelsAbraham Nyska, Anthony Dayan, Robert R Maronpot
The Journal of Gene Medicine|April 16, 2009
A preclinical assessment of the safety and biodistribution of an adenoviral vector containing the herpes simplex virus thymidine kinase gene (Cerepro) after intracerebral administrationGillian Langford, Anthony Dayan, Seppo Yla-Herttuala, et al.
International Journal of Toxicology|April 9, 2025
A Commentary: Looking Back and Looking SidewaysAnthony Dayan, Peter Pressman, Thomas Blackburn, et al.
Archives of Toxicology|June 20, 2021
Categorizing the characteristics of human carcinogens: a need for specificityCarr J Smith, Thomas A Perfetti, A Wallace Hayes, et al.
Science Translational Medicine|July 17, 2015
A long-duration dihydroorotate dehydrogenase inhibitor (DSM265) for prevention and treatment of malariaMargaret A Phillips, Julie Lotharius, Kennan Marsh, et al.
Pageof 1